全球人工器官市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計人造器官市場將從 2025 年的 346.4 億美元成長到 2034 年的 708.1 億美元，2026 年至 2034 年的複合年成長率為 8.27%。

隨著醫療技術的進步，全球人工器官市場正在不斷擴大，以滿足日益成長的器官替代療法需求。人工器官是一種旨在模擬心臟、腎臟和肺部等天然器官功能的醫療設備。這些器械用於幫助器官衰竭或患有嚴重慢性疾病的患者。

多種因素正在推動這一市場的成長。器官衰竭的日益普遍和捐贈器官的短缺，使得人工器官技術的需求強勁。此外，生物醫學工程和醫療設備製造技術的進步，也提高了人工器官的性能和安全性。

由於持續的研究不斷提升設備的功能性和生物相容性，人工器官市場被認為極具發展前景。增加對醫療創新和再生醫學的投資，可望推動更先進的人工器官系統的研發。隨著醫療技術的進步，人工器官預計將在拯救生命的治療中發揮日益關鍵的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球人工器官市場：依器官類型分類

• 市場分析、洞察與預測
• 人工心臟
• 人工心臟瓣膜
• 心室輔助裝置
• 心臟心律調節器
• 人工腎臟
• 人工胰臟
• 人工肺
• 人工電子耳
• 人工肝臟
• 其他

第5章：全球人工器官市場：依材料類型分類

• 市場分析、洞察與預測
• 矽
• 塑膠
• 鋼

第6章：全球人工器官市場：依類型分類

• 市場分析、洞察與預測
• 永久性人工器官
• 臨時人工器官

第7章 全球人工器官市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • B. Braun SE
  • Boston Scientific Corporation
  • Getinge AB
  • Abiomed
  • Asahi Kasei Corporation
  • Berlin Heart
  • Carmat
  • Jarvik Heart Inc
  • Terumo Corporation
  • SynCardia Systems LLC
  • Nipro Europe Group Companies

The Artificial Organs Market size is expected to reach USD 70.81 Billion in 2034 from USD 34.64 Billion (2025) growing at a CAGR of 8.27% during 2026-2034.

The global artificial organs market is expanding as medical technology advances to address the growing demand for organ replacement therapies. Artificial organs are medical devices designed to replicate the function of natural organs such as the heart, kidneys, and lungs. These devices are used to support patients who suffer from organ failure or severe chronic diseases.

Several factors are driving the growth of this market. The increasing prevalence of organ failure and the shortage of donor organs are creating strong demand for artificial organ technologies. Additionally, advancements in biomedical engineering and medical device manufacturing are improving the performance and safety of artificial organs.

The future prospects of the artificial organs market appear highly promising as research continues to improve device functionality and compatibility with the human body. Increasing investments in healthcare innovation and regenerative medicine may lead to the development of more advanced artificial organ systems. As medical technology progresses, artificial organs are expected to play an increasingly important role in life-saving treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Organ Type

• Artificial Heart
• Prosthetic Heart Valves
• Ventricular Assist Devices
• Cardiac Pacemakers
• Artificial Kidney
• Artificial Pancreas
• Artificial Lungs
• Cochlear Implants
• Artificial Liver
• Others

By Material Type

• Silicon
• Plastics
• Steel

By Type

• Permanent Artificial Organs
• Temporary Artificial Organs

COMPANIES PROFILED

• B Braun SE, Boston Scientific Corporation, Getinge AB, Abiomed, Asahi Kasei Corporation, Berlin Heart, Carmat, Jarvik Heart Inc, Terumo Corporation, SynCardia Systems LLC, Nipro Europe Group Companies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL ORGANS MARKET: BY ORGAN TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Organ Type
• 4.2. Artificial Heart Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prosthetic Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ventricular Assist Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cardiac Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Artificial Kidney Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Artificial Pancreas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Artificial Lungs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Cochlear Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Artificial Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL ORGANS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material Type
• 5.2. Silicon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plastics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Steel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL ORGANS MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Permanent Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Temporary Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTIFICIAL ORGANS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Organ Type
  • 7.2.2 By Material Type
  • 7.2.3 By Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Organ Type
  • 7.3.2 By Material Type
  • 7.3.3 By Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Organ Type
  • 7.4.2 By Material Type
  • 7.4.3 By Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Organ Type
  • 7.5.2 By Material Type
  • 7.5.3 By Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Organ Type
  • 7.6.2 By Material Type
  • 7.6.3 By Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTIFICIAL ORGANS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 B. Braun SE
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Getinge AB
  • 9.2.4 Abiomed
  • 9.2.5 Asahi Kasei Corporation
  • 9.2.6 Berlin Heart
  • 9.2.7 Carmat
  • 9.2.8 Jarvik Heart Inc
  • 9.2.9 Terumo Corporation
  • 9.2.10 SynCardia Systems LLC
  • 9.2.11 Nipro Europe Group Companies